{"changes":[],"country":"US","description":"Science Corporation develops neural-interface devices led by PRIMA, a retinal implant restoring functional vision in macular-degeneration patients, plus biohybrid interfaces. It treats AMD, retinitis pigmentosa, and Stargardt patients while serving neural-engineering labs. PRIMA results were published in NEJM.","domain":"sciencecorp.com","employees":null,"founded":2021,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":["khosla","lightspeed"],"lat":39.78373,"lng":-100.445882,"location":"USA","name":"Science Corp","rounds":[{"amountQuarantined":false,"amountUsd":230000000,"currency":"USD","date":"2026-03-01","investors":["khosla","lightspeed"],"leadInvestor":"khosla","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"sciencecorp-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"sciencecorp.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://sciencecorp.com"},{"fact":"description","publisher":"sciencecorp.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://sciencecorp.com"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":230000000,"updatedAt":"2026-05-07"}